Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue. by Wilfredo Oliva-Olivera (301968)

“…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C⁺ and CD163⁺ macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C⁺, CD163⁺: proinflammatory macrophage cell-surface markers.…”

TGFβ increases <i>TGFBR1</i> (ALK5) and decreases <i>ACVRL1</i> (ALK1) in human BMSC pellets. by Laurie M. G. de Kroon (840517)

NB5-2 lineage in gnathal segments. by Christof Rickert (4836519)

NB5-6 lineage in gnathal segments. by Christof Rickert (4836519)

NB5-3 lineage in gnathal segments. by Christof Rickert (4836519)

Fig 5 - by Mísia Helena da Silva Ferro (20623666)

Archazolid decreases the activity and expression of cathepsin B in endothelial cells. by Betty Luong (5738027)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

Treatment of serine protease inhibitor (AEBSF) in the uterus decreases the number of sperm in the oviduct. by Shuai Li (65944)

Fig 5 - by Jeannette Silva-López (16541854)

Knockdown of 1A6/DRIM results in a decrease in 47S rRNA. by Qunhui Peng (358982)

Fig 5 - by Simon Taub (12262035)

vOPG147 is associated with MITA. by Xue-Mei Yi (18851202)

Metal-reactive lymphocytes from individuals’ exhibit significant decreased metal-reactivity in the presence of inflammasome based inhibitors. by Lauryn Samelko (424639)

Effect of treatment with TSA on Aβ42 and Aβ40 levels in APPswe/PS1dE9 transgenic mice. by Li Shen (110858)

Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

“…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”

ECE treatment decreases coronavirus production in the cells. by Siyun Lee (17087351)

“…<p><b>(A)</b> ECE treatment decreased the coronavirus protein in the infected cells. …”

As the number of infections <i>I</i> in a given county increases, the variance in exponential growth rate, Var(Δ<i>I</i>/<i>I</i>), decreases as . by Calvin Pozderac (10451496)

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on oxidative burst capacity of neutrophils after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on peritoneal cellular immune response after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)